Abbott Laboratories

NYSE:ABT 주식 보고서

시가총액: US$202.6b

Abbott Laboratories 대차 대조표 상태

재무 상태 기준 확인 6/6

Abbott Laboratories 의 총 주주 지분은 $40.0B 이고 총 부채는 $15.0B, 이는 부채 대 자기자본 비율을 37.6% 로 가져옵니다. 총자산과 총부채는 각각 $74.4B 및 $34.3B 입니다. Abbott Laboratories 의 EBIT는 $7.6B 이며 이자보상배율은 31.7 입니다. $7.8B 의 현금 및 단기 투자금을 보유하고 있습니다.

주요 정보

37.6%

부채 비율

US$15.05b

부채

이자 보상 비율31.7x
현금US$7.79b
주식US$40.03b
총 부채US$34.33b
총 자산US$74.36b

최근 재무 상태 업데이트

Recent updates

Investors Will Want Abbott Laboratories' (NYSE:ABT) Growth In ROCE To Persist

Oct 31
Investors Will Want Abbott Laboratories' (NYSE:ABT) Growth In ROCE To Persist

Abbott Laboratories: Long-Term Optimism, Short-Term Overvaluation

Oct 21

Abbott: Challenging Comparables, Unappealing Value Limit The Incentive To Go Long Ahead Of Q3 Event

Oct 14

Does Abbott Laboratories (NYSE:ABT) Have A Healthy Balance Sheet?

Oct 11
Does Abbott Laboratories (NYSE:ABT) Have A Healthy Balance Sheet?

Why We're Not Concerned About Abbott Laboratories' (NYSE:ABT) Share Price

Sep 27
Why We're Not Concerned About Abbott Laboratories' (NYSE:ABT) Share Price

Abbott Laboratories: Cardiovascular Disease Has Been A Tailwind, But Things Could Change

Sep 11

A Look At The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)

Aug 16
A Look At The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)

Abbott Laboratories: Driving Value By Scaling Innovations

Aug 13

Abbott Laboratories: A Strong Healthcare Stock For Long-Term Dividend Growth Investors

Aug 05

Abbott Laboratories: When Double-Digit Device Growth Apparently Isn't Enough

Jul 13

These 4 Measures Indicate That Abbott Laboratories (NYSE:ABT) Is Using Debt Reasonably Well

Jul 01
These 4 Measures Indicate That Abbott Laboratories (NYSE:ABT) Is Using Debt Reasonably Well

Abbott Laboratories (NYSE:ABT) Is Doing The Right Things To Multiply Its Share Price

Jun 18
Abbott Laboratories (NYSE:ABT) Is Doing The Right Things To Multiply Its Share Price

Investors Still Waiting For A Pull Back In Abbott Laboratories (NYSE:ABT)

Jun 04
Investors Still Waiting For A Pull Back In Abbott Laboratories (NYSE:ABT)

Abbott Laboratories: Why I Agree With Wall Street On This One

Jun 04

Abbott Laboratories: Buying More Of This Top-Notch Dividend Growth Stock

May 18

Abbott Laboratories: Organic Growth Will Be Key To Q1 Earnings

Apr 17

Estimating The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)

Apr 15
Estimating The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)

Abbott Laboratories: Buy This World-Class Dividend Growth Stock Now

Mar 21

Abbott Laboratories (NYSE:ABT) Might Have The Makings Of A Multi-Bagger

Mar 19
Abbott Laboratories (NYSE:ABT) Might Have The Makings Of A Multi-Bagger

Here's Why Abbott Laboratories (NYSE:ABT) Can Manage Its Debt Responsibly

Mar 06
Here's Why Abbott Laboratories (NYSE:ABT) Can Manage Its Debt Responsibly

Abbott Labs' Reversal Is Here - CGM Tailwinds In 2024

Feb 27

Abbott Laboratories' (NYSE:ABT) Shares May Have Run Too Fast Too Soon

Feb 08
Abbott Laboratories' (NYSE:ABT) Shares May Have Run Too Fast Too Soon

The King Is Back: Abbott Laboratories' Path To >11% Annual Returns

Jan 29

The Abbott Laboratories (NYSE:ABT) Full-Year Results Are Out And Analysts Have Published New Forecasts

Jan 26
The Abbott Laboratories (NYSE:ABT) Full-Year Results Are Out And Analysts Have Published New Forecasts

재무 상태 분석

단기부채: ABT 의 단기 자산 ( $23.8B )이 단기 부채( $14.9B ).

장기 부채: ABT 의 단기 자산( $23.8B )이 장기 부채( $19.4B ).


부채 대 자본 내역 및 분석

부채 수준: ABT 의 순부채 대 자기자본 비율( 18.1% )은 satisfactory로 간주됩니다.

부채 감소: ABT 의 부채 대 자기자본 비율은 지난 5년간 59.6% 에서 37.6% 로 감소했습니다.

부채 범위: ABT 의 부채는 영업 현금 흐름 ( 58% )에 의해 잘 충당되었습니다.

이자 보장: ABT 의 부채에 대한 이자 지급EBIT( 31.7 x 적용 범위)로 잘 충당됩니다.


대차 대조표


건강한 기업 발견하기